Eflornithine Hydrochloride

FDA Drug Profile

Eflornithine Hydrochloride is listed in the FDA National Drug Code directory with 2 NDC codes. Available dosage form: powder.

Drug details

Generic Name
Eflornithine Hydrochloride
Sponsor
SciAnda (Changshu) Pharmaceuticals, Ltd.
NDC Codes
2
Dosage Forms
POWDER
Active Ingredients
EFLORNITHINE HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE IWILFIN (eflornithine) is indicated to reduce the risk of relapse in adult and pediatric patients with high-risk neuroblastoma (HRNB) who have demonstrated at least a partial response to prior multiagent, multimodality therapy including anti-GD2 immunotherapy. IWILFIN is an ornithine decarboxylase inhibitor indicated to reduce the risk of relapse in adult and pediatric patients with high-risk neuroblastoma (HRNB) who have demonstrated at least a partial response to prior multiagent, multimodality therapy including anti-GD2 immunotherapy. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.